NORTHCLIFF ANNOUNCES NON-BROKERED PRIVATE PLACEMENT FINANCING
VANCOUVER, BC, June 19, 2025 /CNW/ - Northcliff Resources Ltd. ("Northcliff" or the "Company") (TSX: NCF) announces that it has arranged a non-brokered private placement (the "Private Placement") of 19,842,128 common shares of the Company ("Common Shares") at a price of C$0.06 per Common Share (based on the five day VWAP of the Common Shares for the five trading days ended May 29, 2025) for gross proceeds of C$1,190,527.68. The Common Shares issued are subject to applicable resale restrictions, including a hold period of four months and one day from the closing of the Private Placement under Canadian securities rules. The Private Placement is subject to customary closing conditions including final Toronto Stock Exchange approval. Proceeds of the Private Placement will be used to fund the Company's share of expenditures related to the Sisson Project and for working capital and general corporate purposes.
Todd Sisson (NZ) Limited ("Todd"), a subsidiary of the Todd Corporation and a shareholder that holds in excess of 10% of the issued and outstanding Common Shares, will subscribe for 16,157,166 Common Shares under the Private Placement. Andrew Ing, a director and officer of the Company, will subscribe for 323,242 Common Shares under the Private Placement and Scott Cousens, a director of the Company, will subscribe for 1,292,970 Common Shares under the Private Placement. Additionally, Barb Thomas, the spouse of Trevor Thomas, an officer of the Company, will subscribe for 77,578 Common Shares under the Private Placement. Each of Todd, Andrew Ing, Scott Cousens and Barb Thomas are considered to be "insiders" by the Toronto Stock Exchange.
The participation by each of Todd, Andrew Ing and Scott Cousens constitutes a "related party transaction" within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company is relying upon the exemptions from the formal valuation and minority shareholder approval requirements pursuant to sections 5.5(a) and 5.7(1)(a), respectively, of MI 61-101 on the basis that neither the fair market value of the subject matter of, nor the fair market value of the consideration for, the transaction insofar as it involves interested parties (within the meaning of MI 61-101) in the Private Placement exceeds 25% of the Company's market capitalization calculated in accordance with MI 61-101.
As the terms of the Private Placement, including insider participation, were only recently finalized, the Company will file a material change report less than 21 days before the expected closing of the Private Placement. The Company believes this shorter period is reasonable in the circumstances in order to complete the Private Placement in a timely and efficient manner.
Upon closing of the Private Placement, Todd shall exercise its right to nominate a second director, Mr. Evan Davies, to the Company's Board of Directors.
Mr. Davies has been a senior executive at Todd since 2008 and has been Group CEO since early 2023. He has significant commercial and management experience across a range of industries. Before joining Todd as Managing Director of Todd Property, he was the initial Managing Director of SkyCity Entertainment Group, growing the company from a single site to having business operations throughout New Zealand, South Australia and the Northern Territory with an enterprise value of NZ$3 billion and more than 6,000 staff. He also has business interests in farming and viticulture and is involved with several charitable and public sector enterprises. Mr. Davies holds a Bachelor of Town Planning from the University of Auckland, a Master of Science in Tourism Management from the University of Surrey and a Master of Philosophy in Urban and Regional Planning from the University of Birmingham.
Northcliff Chairman, President and CEO Andrew Ing said "On behalf of the Northcliff Board of Directors, I would like to welcome Evan Davies to the Board and look forward to the benefit of his business expertise and strategic advice as we progress the Sisson Critical Minerals Project."
About Northcliff Resources Ltd.
Northcliff is a mineral resource company focused on advancing the Sisson Tungsten-Molybdenum Project located in New Brunswick, Canada, to production.
Additional information on Northcliff is available on the website at www.northcliffresources.com. Investor services can be reached at (604) 684-6365 or within North America at 1-800-667-2114.
On behalf of the Board of Directors
Andrew Ing
Chairman, President & CEO
This release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address the proposed Private Placement, or other events that the Company expects, are forward looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. For more information on the Company, investors should review the Company's continuous disclosure filings that are available at www.sedarplus.ca.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Edmonton Journal
20 minutes ago
- Edmonton Journal
Friday's letters: Edmonton should separate from Alberta
For the safety and prosperity of all fellow residents, if Alberta tries to separate from Canada, Edmonton must separate from Alberta. As a Canadian enclave freed from the shackles of the polluting oil and gas industry holding us back from diversification, we would be Canada's sixth-largest provincial economy by GDP and fifth-largest province by population.
Toronto Star
42 minutes ago
- Toronto Star
Despite lower rents, many tenants report spending less on food and taking on credit card debt to make ends meet
Even though rent prices in Toronto and across Canada have declined in recent months, they are still high enough that many renters are spending less on food and accumulating debt to make their monthly payments, a new report says. According to the Royal LePage 2025 Canadian Renters Report, Canadian rent prices are 5.7 per cent higher than they were two years ago and 12.6 per cent higher than they were three years ago.
Global News
2 hours ago
- Global News
New Purdue opioid crisis settlement builds ‘momentum' for Canada: B.C. AG
Recent settlements in U.S. government lawsuits against opioid manufacturer Purdue Pharma and the firm that allegedly consulted on boosting its sales have B.C.'s attorney general feeling 'heartened' as she pursues similar lawsuits in Canada. Monday saw 55 U.S. states and territories reach a US$7.5-billion settlement with Purdue, the maker of OxyContin, and members of the Sackler family that sought to hold them accountable for contributing to the opioid overdose crisis. As part of the settlement, the Sacklers will give up their control of the bankrupt company and will be barred from selling prescription opioids in the future. A federal judge said Wednesday that he will rule Friday on a plan for local governments and individual victims, who would also be entitled to compensation, to vote on approving the settlement by September, allowing it to proceed. Story continues below advertisement The announcement of the U.S. settlement came after the B.C. Supreme Court on Friday certified a class-action lawsuit by the province against McKinsey & Company, which is accused of advising Purdue and other drugmakers on how to market their opioid products in Canada. McKinsey has already had to pay over US$1 billion in penalties to settle similar lawsuits in the U.S., which also led to jail time for a McKinsey executive. 'I'm really pleased with the momentum,' B.C. Attorney General Niki Sharma told Global News in an interview. 'My job as attorney general is to make sure we pursue it very aggressively and as quickly as we can, so I am heartened by the success in the States and will keep on leading the charge here in Canada.' The B.C. lawsuit against McKinsey is separate from a larger class action against dozens of opioid manufacturers and distributors on allegations they downplayed the risk their products posed in order to rake in profits. That lawsuit was allowed to go ahead last fall and was certified in January. 2:00 Supreme Court upholds B.C. opioid lawsuit B.C. is leading both lawsuits on behalf of the other Canadian provinces and territories and the federal government, with the goal of recovering health-care costs that went toward responding to the overdose crisis, Sharma said. Story continues below advertisement 'We think it's unfair that companies that profited so much, knowing that their product was so harmful and that would cause this level of addiction, aren't paying for the costs of health care,' she said. A spokesperson for McKinsey told Global News it intends to defend itself against the lawsuit, which the company says is without merit. 'McKinsey did not undertake any work in Canada to enhance the sale or marketing of opioids,' the spokesperson said in an email. Alleged tactics to 'turbocharge' opioid sales B.C.'s lawsuit against McKinsey alleges the Canadian subsidiaries of Purdue, as well as Johnson & Johnson, Janssen and other drugmakers, employed many of the same tactics used by U.S. parent companies to boost their sales. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy The B.C. Supreme Court, in certifying the lawsuit, noted in its decision that multinational companies often apply business and marketing strategies 'universally.' Story continues below advertisement Last December, McKinsey agreed to pay U$650 million to resolve a U.S. Justice Department lawsuit that focused on the firm's work with Purdue, including allegations that McKinsey advised on steps to 'turbocharge' sales of OxyContin. Martin Elling, a former McKinsey senior partner who worked on Purdue matters, was sentenced to six months in prison after pleading guilty to obstruction of justice related to that case. 2:42 Conservatives grill Trudeau on former McKinsey head connection ahead of committee appearance The federal settlement was on top of a combined US$641 million McKinsey agreed to pay in 2021 to resolve similar claims brought by U.S. state attorneys general. In total, federal and state lawsuits related to the opioid crisis have resulted in roughly US$50 billion in settlements, according to researchers from Johns Hopkins University who track such claims. Long-term heavy use of prescription painkillers like OxyContin due to dependence contributed to a majority of opioid-related hospitalizations and overdoses in the early 2000s across North America. In recent years, illicit opioids like fentanyl have overtaken prescription opioids as the primary driver of the opioid crisis. Story continues below advertisement Between 2016 and last September, nearly 51,000 Canadians have died of an opioid-related overdose, according to federal data. B.C., which declared a public health emergency in 2016, saw the most fatal overdoses of any other province during that time, with more than 16,000 deaths. 'I think like many provinces across this country, we've really seen the toll of the opioid crisis on people not only with long-lasting addictions and impacts there, but loss of life and a lot of people that are mourning the loss of their loved ones,' Sharma said. A spokesperson for Health Canada said the federal government 'believes companies should be held accountable for their role in the overdose crisis' and will continue to work with provinces and territories on B.C.'s legal actions. 'The overdose crisis continues to be one of Canada's most pressing public health challenges,' the spokesperson said in an email to Global News. Health Canada is reviewing and 'considering' developments from the recent Purdue settlement in the U.S., the statement added. Where should the money go? In 2022, B.C. secured a $150-million settlement on behalf of Canadian governments in a class action against Purdue. The settlement was finalized in early 2023, allowing individuals to submit claims from a $20-million portion set aside for victims and their families, a process that remains ongoing. Story continues below advertisement The pending lawsuit against opioid manufacturers and distributors names Purdue and its various subsidiaries, as well as Johnson & Johnson, Janssen and Canadian companies like Loblaw and its subsidiary Shoppers Drug Mart. It remains in litigation. 5:09 B.C. government steps up legal action against opioid drug makers Researchers writing in the International Journal of Drug Policy earlier this year urged Canadian governments to ensure funds recovered from opioid lawsuit settlements go directly toward combating the drug crisis, rather than unrelated government expenses. Those measures should include funding harm reduction services like overdose prevention centres and safe drug supplies, as well as community organizations that work directly with people suffering from addiction, the paper says. Efforts to track how U.S. state and local governments are spending their opioid settlement money have uncovered several examples of funds not being used to directly respond to the opioid crisis. Story continues below advertisement Canada is being urged to avoid similar 'pitfalls' by mandating that at least 85 per cent of recovered funds be allocated to 'opioid remediation efforts,' and working directly with community organizations and members affected by addiction. Proposed guidelines by researchers at Johns Hopkins University for how U.S. opioid settlement funds should be spent have been adopted in over 25 states, according to the university. Sharma said B.C.'s lawsuits are structured so that any funds recovered by the province will be mandated to go to the health-care system, but that could evolve depending on how settlements are structured. 'It may be that as this develops, and the opioid cases develop, it will be tied to organizations that do addictions treatment, or there could be a whole range of things that go directly towards this crisis,' she said. She pointed to the record $32.5-billion settlement B.C. won in March on behalf of Canadian governments in its lawsuit against the tobacco industry as a model both of the province's health-related legal advocacy and the results it can achieve. 'We are really focused on eliminating the bad actors,' she said. 'It's really important to make sure that we set a line in the sand about what's right and what isn't right with the conduct of all companies out there.'
